Alder Biopharmaceuticals Inc (NASDAQ:ALDR) Files An 8-K

Alder Biopharmaceuticals Inc (NASDAQ:ALDR) promoted Larry K. Benedict to the position of Executive Vice President and Principal Accounting Officer from his previous position of Senior Vice President, Finance (and in such capacity, Mr. Benedict will continue to serve as Alder’s principal financial officer and principal accounting officer, as defined under applicable securities laws). In connection with the promotion, Mr. Benedict’s annual base salary for 2016 was increased to $316,800 and his target bonus for 2016 was increased to 33% of his annual base salary. In addition, Mr. Benedict was a granted an option under Alder’s 2014 Equity Incentive Plan to purchase 30,000 shares of Alder’s common stock at an exercise price of $30.20 per share. The 2014 Equity Incentive Plan and the form of option agreement under the 2014 Equity Incentive Plan were filed as Exhibits 10.4 and 10.5, respectively, to Alder’s Form S-1 (File No. 333-194672) filed with the Securities and Exchange Commission on April 25, 2014.

An ad to help with our costs